About Melanotan Source

What This Site Is

Melanotan Source is a source record of the peer-reviewed research literature on melanotan — Melanotan I (afamelanotide) and Melanotan II — indexed and cited. It keeps no clinic and no clinician, hands out no medical advice, and has nothing to sell, source, or ship. What it maintains is a reading of published science, indexed to source.

The domain modifier 'source' is an editorial position — we are the source record of the melanotan research literature, indexed and cited. It does not imply we are a supplier, vendor, or distributer of any compound. The site has no commercial relationship with any manufacturer, seller, or distributor of peptide compounds.

What This Site Is Not

We are not a telehealth service, a compounding pharmacy, or a clinical provider. We do not fill prescriptions. We do not recommend compounds for any use. We do not direct readers to sources of any compound. The negative terms — buy melanotan, melanotan for sale, melanotan supplier, melanotan vendor — do not apply to this site in any sense.

The melanotan research literature includes both promising preclinical and Phase I clinical findings AND serious documented adverse events (renal infarction, rhabdomyolysis, dysplastic nevi, and mucosal malignant melanoma in case reports of self-administered uncontrolled use). We document both tiers of the evidence equally. A reader who wants only the positive findings from this record is not reading the full record.

Editorial Standards

Every quantitative claim on this site maps to a numbered citation in the reference index. Every citation is PubMed-indexed or peer-reviewed journal-indexed. We do not write findings not in the published literature. We do not recommend doses for human use.

The site uses the technical-trust voice: spare, specific, subject-verb-object. Data first. Attribution after. The drill-down organization — breadcrumb paths, parent-metric strips, expanding disclosure tiers — reflects the hierarchical structure of the science itself: from receptor to cascade to clinical outcome to adverse event. The reader controls how deep they drill.

If you identify a factual error or a citation that resolves incorrectly, the contact page is open. We update content when the published literature updates.